Acromegaly: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 16: | Line 16: | ||
{{CMG}} {{AE}} {{AEL}} | {{CMG}} {{AE}} {{AEL}} | ||
{{SK}} Somatotroph adenoma; | {{SK}} Somatotroph adenoma; Growth hormone excess; Pituitary giant. | ||
==[[Acromegaly overview|Overview]]== | ==[[Acromegaly overview|Overview]]== | ||
Latest revision as of 19:21, 30 October 2017
For patient information click here
Acromegaly | |
![]() | |
---|---|
Acromegaly. Image courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, California | |
ICD-10 | E22.0 |
ICD-9 | 253.0 |
OMIM | 102200 |
DiseasesDB | 114 |
MeSH | D000172 |
Acromegaly Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acromegaly On the Web |
American Roentgen Ray Society Images of Acromegaly |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Synonyms and keywords: Somatotroph adenoma; Growth hormone excess; Pituitary giant.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acromegaly from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory findings | x ray | CT | MRI | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical Therapy | Surgery | Radiation Therapy | Primary Prevention | Secondary Prevention| Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related chapters
bg:Акромегалия cs:Akromegalie de:Akromegalie gl:Acromegalia it:Acromegalia he:אקרומגליה nl:Acromegalie no:Akromegali sq:Akromegalia sk:Akromegália sr:Акромегалија fi:Akromegalia sv:Akromegali uk:Акромегалія